Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study.

Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E.

J Urol. 2000 Feb;163(2):490-5.

PMID:
10647663
2.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
3.

The natural history of benign prostatic hyperplasia.

Fitzpatrick JM.

BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. Review.

5.

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.

Parsons JK, Kashefi C.

Eur Urol. 2008 Jun;53(6):1228-35. doi: 10.1016/j.eururo.2008.02.019. Review.

PMID:
18358592
6.

Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations.

Hoke GP, McWilliams GW.

Am J Med. 2008 Aug;121(8 Suppl 2):S3-10. doi: 10.1016/j.amjmed.2008.05.021. Review.

PMID:
18675615
7.

Benign prostatic hyperplasia: natural evolution versus medical treatment.

Da Silva FC.

Eur Urol. 1997;32 Suppl 2:34-7. Review.

PMID:
9248811
8.

Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.

Boyle P, McGinn R, Maisonneuve P, La Vecchia C.

Eur Urol. 1991;20 Suppl 1:3-10. Review.

PMID:
1722158
9.

Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.

Napalkov P, Maisonneuve P, Boyle P.

Urology. 1995 Sep;46(3 Suppl A):41-6. Review.

PMID:
7544516
10.

The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension.

Boyle P, Napalkov P.

Scand J Urol Nephrol Suppl. 1995;168:7-12. Review.

PMID:
7541551
11.

Epidemiology and natural history of benign prostatic hyperplasia.

Tsukamoto T, Masumori N.

Int J Urol. 1997 May;4(3):233-46. Review. No abstract available.

Items per page

Supplemental Content

Support Center